IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — SRCO

Balance Sheet

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021
Cash & Equivalents0.070.030.050.050.090.140.010.000.010.000.000.000.030.000.000.03
Accounts Receivable0.010.010.000.010.000.010.000.000.000.000.000.000.000.000.000.02
Inventory0.000.000.000.000.010.000.000.000.000.010.000.010.010.010.010.02
Total Current Assets0.920.850.840.820.630.360.010.010.010.010.010.010.040.020.010.06
Total Non-current Assets*0.010.010.010.010.010.010.010.010.010.010.010.010.020.020.020.02
Total Assets0.930.860.850.830.640.370.020.020.020.020.020.020.060.040.030.08
Accounts Payable1.421.371.361.321.321.301.591.551.501.753.474.433.534.043.853.03
Short-term Debt0.000.00--0.007.497.39----------0.140.140.390.390.41
Total Current Liabilities11.3911.1310.8010.8810.469.719.779.929.6913.4515.1417.8317.2416.8011.3512.45
Long-term Debt--0.818.708.117.837.295.515.565.165.465.415.315.235.214.724.73
Total Non-current Liabilities0.750.790.940.400.340.740.620.630.610.390.440.440.430.430.430.43
Total Liabilities12.1411.9211.7411.2810.8010.4510.3910.5610.3013.8415.5818.2717.6817.2311.7812.88
Retained Earnings(70.34)(69.93)(69.40)(68.59)(68.18)(67.76)(66.79)(66.73)(66.36)(69.45)(70.53)(72.88)(71.47)(69.74)(64.61)(65.21)
Total Stockholder Equity(12.25)(12.09)(11.92)(11.46)(11.17)(11.08)(11.35)(11.51)(11.25)(14.82)(16.55)(19.24)(18.59)(18.18)(12.73)(13.78)

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Total Revenue0.060.090.100.100.070.080.050.040.040.040.050.060.070.060.060.070.060.120.070.06
Cost of Revenue0.010.010.010.010.010.010.000.010.010.010.010.010.010.010.010.01-0.000.020.010.01
Gross Profit0.050.090.090.090.060.070.040.030.030.030.040.050.060.050.040.06-0.000.100.050.05
Research & Development--------------------------0.000.000.04--------
Selling, General & Admin0.080.040.040.060.060.040.050.05(0.10)0.080.090.11(0.99)0.400.300.530.100.590.260.25
Total Operating Expenses1.400.290.360.370.430.260.370.380.150.250.300.32(2.89)0.400.300.570.370.590.260.25
Operating Income(1.35)(0.21)(0.27)(0.28)(0.37)(0.19)(0.33)(0.34)(0.12)(0.22)(0.27)(0.26)(0.27)(0.35)(0.26)(0.51)(0.38)(0.49)(0.20)(0.20)
Net Income(1.45)(0.41)(0.52)(0.47)(0.33)(0.41)(0.42)(0.96)(0.06)(0.10)(0.57)(0.21)(2.29)1.092.361.11(2.64)(1.61)(5.12)0.38
Basic EPS--(0.01)(0.01)(0.01)(0.01)(0.01)(0.01)(0.03)0.01-0.00(0.01)(0.01)(0.10)(0.05)0.130.07--------
Diluted EPS--(0.01)(0.01)(0.01)(0.01)(0.01)(0.01)(0.03)0.01-0.00(0.01)(0.01)(0.10)--------------

Cash Flow Statement

(in millions USD)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022
Operating Cash Flow(0.05)(0.18)(0.19)(0.35)(0.05)(0.18)(0.55)(0.45)(0.72)(0.06)(0.19)(0.25)(2.04)(0.35)(0.45)(0.25)(0.70)(0.40)0.00(0.07)
Financing Cash Flow0.100.220.180.260.130.130.510.490.810.060.190.26(4.14)0.350.450.250.670.43-0.000.07